Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone-derived proteins.

S Epstein1

  • 1Albert Einstein Medical Center at the Temple University School of Medicine, Philadelphia, PA 19141, USA.

Trends in Endocrinology and Metabolism: TEM
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Diagnosing metabolic bone disease is challenging due to limited understanding of bone cell function. Bone Gla protein (BGP) shows promise as a biomarker, but requires use with other tests for effective diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-related maximal heart rate: examination and refinement of prediction equations.

The Journal of sports medicine and physical fitness·2014
Same author

Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Special Care: a continuation of growth.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·2013
Same author

Tools in the assessment of sarcopenia.

Calcified tissue international·2013
Same author

What is Responsible for the Rise in Lung Cancer Mortality?

New solutions : a journal of environmental and occupational health policy : NS·2012
Same author

Does plasma IGF-BP3 measurement contribute to the diagnosis of growth hormone deficiency in children?

Annales d'endocrinologie·2011
Same journal

HDL resuscitates cells from ferroptosis.

Trends in endocrinology and metabolism: TEM·2026
Same journal

2-Methylbutyrylcarnitine (2MBC).

Trends in endocrinology and metabolism: TEM·2026
Same journal

Decoding growth hormone actions on human growth plate stem cells.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Androgen loss backfires: Brain gate for tumor immunity.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Glucocorticoid resistance-induced inflammation drives cardiovascular-kidney-metabolic (CKM) syndrome pathophysiology.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Hippo signalling in cellular and tissue-level metabolism across health and disease.

Trends in endocrinology and metabolism: TEM·2026
See all related articles

Area of Science:

  • Biochemistry
  • Endocrinology
  • Orthopedics

Background:

  • Metabolic bone disease diagnosis and treatment are hindered by incomplete knowledge of bone cell physiology.
  • Lack of specific markers for bone cell functions complicates disease assessment.

Purpose of the Study:

  • To evaluate the diagnostic utility of bone-derived proteins, particularly noncollagenous proteins, in metabolic bone diseases.
  • To identify reliable biomarkers for assessing bone cell activity and disease progression.

Main Methods:

  • Measurement of serum noncollagenous proteins, including bone Gla protein (BGP).
  • Comparative analysis of BGP with other potential markers and diagnostic tests.

Main Results:

  • Bone Gla protein (BGP) emerges as a potentially useful biomarker for metabolic bone diseases.

Related Experiment Videos

  • Optimal diagnostic value of BGP is achieved when used in conjunction with other established tests.

    • Conclusions:

    • Further research is needed to fully document the diagnostic utility of other noncollagenous proteins, procollagen, and local factors.
    • Bone Gla protein (BGP) represents a significant advancement but requires integrated testing for comprehensive metabolic bone disease assessment.